Intermediate-dose immune tolerance induction outperforms with faster success, less bleeding, and no added cost in comparison with low dose: a multicenter randomized clinical trial
一项多中心随机临床试验表明,与低剂量相比,中等剂量免疫耐受诱导疗法具有起效更快、出血更少且不增加成本的优势。
期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2024.102639
Li, Zhengping; Li, Zekun; Cheng, Xiaoling; Zhang, Heng; Yang, Can; Xu, Qian; Chen, Zhenping; Zhen, Yingzi; Li, Gang; Liu, Guoqing; Yao, Wanru; Zhou, Min; Jin, Jiao; Huang, Jie; Fang, Yongjun; Xie, Liangzhi; Poon, Man-Chiu; Wu, Runhui